Olivia Giddings, MD, PhD
Specialty: Pediatric Pulmonology
- Assistant Program Director, Adult CF Center, UH Rainbow Babies and Children's Hospital
- Clinical Assistant Professor, CWRU School of Medicine
- Director, Primary Ciliary Dyskinesia Center, UH Rainbow Babies and Children's Hospital
Olivia Giddings, MD has been a specialist and clinical educator in pediatric pulmonary (lung) disease in the Division of Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine at University Hospitals Rainbow Babies & Children’s Hospital since 2018. She sees patients at the UH Rainbow Babies & Children’s main campus in Cleveland, OH.
Dr. Gidding serves as an attending for the fellow's adult Cystic Fibrosis rotations and is a lecturer in the fellowship's core lecture series within the Primary Ciliary Dyskinesia Center.
Dr. Gidding is board certified in critical care medicine, internal medicine, pediatric pulmonology, pulmonary disease and pediatrics. Her academic interests also include Cystic Fibrosis, transitions of care and Primary Ciliary Dyskinesia.
- Critical Care Medicine
- Pediatric and Adult Cystic Fibrosis
- Primary Ciliary Dyskinesia
- Critical Care Medicine - American Board of Internal Medicine
- Pediatric Pulmonology - American Board of Pediatrics
- Pulmonary Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
University Of North Carolina Health Care (2015 - 2018)
Fellowship | Pulmonary/Critical Care
Pulmonary/Critical Care - University Of North Carolina Health Care (2012 - 2017)
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - Vanderbilt University Medical Center (2008 - 2012)
St Louis University School Of Medicine (2008)
St Louis University (2007)
Dartmouth College (1998)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Olivia Giddings did not disclose any Outside Relationships with Industry.